Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zabrina L Brumme

Showing results (71-80 of 210) with videos related to

Pageof 21
Sort By:
Journal of Virology|August 12, 2016
Novel Acylguanidine-Based Inhibitor of HIV-1Philip Mwimanzi, Ian Tietjen, Scott C Miller, et al.
Plos One|April 6, 2012
Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trialJonathan Z Li, Chanson J Brumme, Michael M Lederman, et al.
Current HIV/AIDS Reports|March 4, 2020
The Impact of Treatment as Prevention on the HIV Epidemic in British Columbia, CanadaViviane D Lima, Zabrina L Brumme, Chanson Brumme, et al.
Journal of Virology|January 16, 2015
Immune screening identifies novel T cell targets encoded by antisense reading frames of HIV-1Christoph T Berger, Anuska Llano, Jonathan M Carlson, et al.
The Journal of Infectious Diseases|May 2, 2007
Effects of human leukocyte antigen class I genetic parameters on clinical outcomes and survival after initiation of highly active antiretroviral therapyZabrina L Brumme, Chanson J Brumme, Celia Chui, et al.
Journal of Virology|February 1, 2013
Frequent and variable cytotoxic-T-lymphocyte escape-associated fitness costs in the human immunodeficiency virus type 1 subtype B Gag proteinsChristian L Boutwell, Jonathan M Carlson, Tien-Ho Lin, et al.
Journal of Virology|March 2, 2012
Widespread impact of HLA restriction on immune control and escape pathways of HIV-1Jonathan M Carlson, Jennifer Listgarten, Nico Pfeifer, et al.
Plos One|March 21, 2015
Modest attenuation of HIV-1 Vpu alleles derived from elite controller plasmaJingyan Chen, Nadine Tibroni, Daniel Sauter, et al.
AIDS Research and Human Retroviruses|February 5, 2008
CD4-dependent characteristics of coreceptor use and HIV type 1 V3 sequence in a large population of therapy-naive individualsAndrew J Low, David Marchant, Chanson J Brumme, et al.
Plos One|March 9, 2016
Rapid HIV-1 Disease Progression in Individuals Infected with a Virus Adapted to Its Host PopulationJiro Katoh, Ai Kawana-Tachikawa, Akihisa Shimizu, et al.
Pageof 21

Showing results (71-80 of 210) with videos related to

Sort By:
Pageof 21
Journal of Virology|August 12, 2016
Novel Acylguanidine-Based Inhibitor of HIV-1Philip Mwimanzi, Ian Tietjen, Scott C Miller, et al.
Plos One|April 6, 2012
Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trialJonathan Z Li, Chanson J Brumme, Michael M Lederman, et al.
Current HIV/AIDS Reports|March 4, 2020
The Impact of Treatment as Prevention on the HIV Epidemic in British Columbia, CanadaViviane D Lima, Zabrina L Brumme, Chanson Brumme, et al.
Journal of Virology|January 16, 2015
Immune screening identifies novel T cell targets encoded by antisense reading frames of HIV-1Christoph T Berger, Anuska Llano, Jonathan M Carlson, et al.
The Journal of Infectious Diseases|May 2, 2007
Effects of human leukocyte antigen class I genetic parameters on clinical outcomes and survival after initiation of highly active antiretroviral therapyZabrina L Brumme, Chanson J Brumme, Celia Chui, et al.
Journal of Virology|February 1, 2013
Frequent and variable cytotoxic-T-lymphocyte escape-associated fitness costs in the human immunodeficiency virus type 1 subtype B Gag proteinsChristian L Boutwell, Jonathan M Carlson, Tien-Ho Lin, et al.
Journal of Virology|March 2, 2012
Widespread impact of HLA restriction on immune control and escape pathways of HIV-1Jonathan M Carlson, Jennifer Listgarten, Nico Pfeifer, et al.
Plos One|March 21, 2015
Modest attenuation of HIV-1 Vpu alleles derived from elite controller plasmaJingyan Chen, Nadine Tibroni, Daniel Sauter, et al.
AIDS Research and Human Retroviruses|February 5, 2008
CD4-dependent characteristics of coreceptor use and HIV type 1 V3 sequence in a large population of therapy-naive individualsAndrew J Low, David Marchant, Chanson J Brumme, et al.
Plos One|March 9, 2016
Rapid HIV-1 Disease Progression in Individuals Infected with a Virus Adapted to Its Host PopulationJiro Katoh, Ai Kawana-Tachikawa, Akihisa Shimizu, et al.
Pageof 21